|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030193,
umls-concept:C0035363,
umls-concept:C0035647,
umls-concept:C0036525,
umls-concept:C0038952,
umls-concept:C0127400,
umls-concept:C0205214,
umls-concept:C0538927,
umls-concept:C0600688,
umls-concept:C0671970,
umls-concept:C0814225,
umls-concept:C1363844,
umls-concept:C1522484,
umls-concept:C1527249,
umls-concept:C1565860,
umls-concept:C1705323
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-6-6
|
|
pubmed:abstractText |
COX-2 activation may mediate capecitabine induced toxicities, eg, hand-foot syndrome (HFS) and colorectal cancer progression, both of which may be improved by concurrent celecoxib.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1537-453X
|
|
pubmed:author |
pubmed-author:AyersGregory DGD,
pubmed-author:BrownThomasT,
pubmed-author:CraneChristopher CCC,
pubmed-author:CurleySteven ASA,
pubmed-author:DelcosMarcM,
pubmed-author:FeigBarryB,
pubmed-author:JanjanNoraN,
pubmed-author:LinEdward HEH,
pubmed-author:MorrisJeffreyJ,
pubmed-author:Rodriguez-BigasMiguel AMA,
pubmed-author:RossAliciaA,
pubmed-author:SkibberJohnJ,
pubmed-author:VadhanSaroj-RajSR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
232-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16755175-Administration, Oral,
pubmed-meshheading:16755175-Aged,
pubmed-meshheading:16755175-Aged, 80 and over,
pubmed-meshheading:16755175-Antimetabolites, Antineoplastic,
pubmed-meshheading:16755175-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16755175-Colorectal Neoplasms,
pubmed-meshheading:16755175-Deoxycytidine,
pubmed-meshheading:16755175-Disease Progression,
pubmed-meshheading:16755175-Female,
pubmed-meshheading:16755175-Fluorouracil,
pubmed-meshheading:16755175-Humans,
pubmed-meshheading:16755175-Male,
pubmed-meshheading:16755175-Middle Aged,
pubmed-meshheading:16755175-Pain,
pubmed-meshheading:16755175-Peripheral Nervous System Diseases,
pubmed-meshheading:16755175-Pyrazoles,
pubmed-meshheading:16755175-Retrospective Studies,
pubmed-meshheading:16755175-Sulfonamides,
pubmed-meshheading:16755175-Survival Analysis,
pubmed-meshheading:16755175-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?
|
|
pubmed:affiliation |
Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. elin@mdanderson.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
